EHNA

Chemical compound

This article may be too technical for most readers to understand. Please help improve it to make it understandable to non-experts, without removing the technical details. (March 2021) (Learn how and when to remove this message)

|

Pharmaceutical compound

EHNA

Identifiers

IUPAC name

* 3-(6-aminopurin-9-yl)nonan-2-ol

CAS Number|

* 59262-86-1

PubChem CID|

* 3206

ChemSpider|

* 3094

ChEMBL|

* ChEMBL50378 Y

CompTox Dashboard (EPA)|

* DTXSID70110044

Chemical and physical data
Formula| C14H23N5O
Molar mass| 277.372 g·mol−1
3D model (JSmol)|

* Interactive image

SMILES

* CCCCCCC(C(C)O)n1cnc2c1ncnc2N

InChI

* InChI=1S/C14H23N5O/c1-3-4-5-6-7-11(10(2)20)19-9-18-12-13(15)16-8-17-14(12)19/h8-11,20H,3-7H2,1-2H3,(H2,15,16,17)

* Key:IOSAAWHGJUZBOG-UHFFFAOYSA-N

(verify)

EHNA (erythro-9-(2-hydroxy-3-nonly)adenine) is a potent adenosine deaminase inhibitor,[1] which also acts as a phosphodiesterase inhibitor that selectively inhibits phosphodiesterase type 2 (PDE2).[2][3]

## References

[edit]

1. ^ "Sigma Aldrich". Retrieved 16 January 2013.
2. ^ Podzuweit T, Nennstiel P, Müller A (September 1995). "Isozyme selective inhibition of cGMP-stimulated cyclic nucleotide phosphodiesterases by erythro-9-(2-hydroxy-3-nonyl) adenine". Cellular Signalling. 7 (7): 733–8\. doi:10.1016/0898-6568(95)00042-N. PMID 8519602.
3. ^ Méry PF, Pavoine C, Pecker F, Fischmeister R (July 1995). "Erythro-9-(2-hydroxy-3-nonyl)adenine inhibits cyclic GMP-stimulated phosphodiesterase in isolated cardiac myocytes" (PDF). Molecular Pharmacology. 48 (1): 121–30\. doi:10.1016/S0026-895X(25)10036-9. PMID 7623766.

* v
* t
* e

Phosphodiesterase inhibitors

PDE1|

* MMPX
* SCH-51866
* Vinpocetine

PDE2|

* BAY 60-7550
* Carbazeran
* EHNA
* Oxindole
* PDP

PDE3|

* Adibendan
* Amrinone (inamrinone)
* Anagrelide
* Benafentrine
* Bucladesine
* Carbazeran
* Cilostamide
* Cilostazol
* Enoximone
* Ensifentrine
* Imazodan
* KMUP-1
* Meribendan
* Milrinone
* Olprinone
* Parogrelil
* Pimobendan
* Pumafentrine
* Quazinone
* RPL-554
* Siguazodan
* Trequinsin
* Vesnarinone
* Zardaverine

PDE4|

* Apremilast
* Arofylline
* Atizoram
* Benafentrine
* Catramilast
* CC-1088
* CDP-840
* CGH-2466
* Cilomilast
* Cipamfylline
* Crisaborole
* Denbutylline
* Difamilast
* Drotaverine
* Ensifentrine
* Etazolate
* Filaminast
* Glaucine
* HT-0712
* ICI-63197
* Indimilast
* Irsogladine
* Lavamilast
* Lirimilast
* Lotamilast
* Luteolin
* Mesembrenone
* Mesembrine
* Mesopram
* Oglemilast
* Piclamilast
* Pumafentrine
* Revamilast
* Ro 20-1724
* Roflumilast
* Rolipram
* Ronomilast
* RPL-554
* RS-25344
* Tetomilast
* Tofimilast
* YM-976
* Zardaverine

PDE5|

* Acetildenafil
* Aildenafil
* Avanafil
* Beminafil
* Benzamidenafil
* Dasantafil
* Icariin
* Gisadenafil
* Homosildenafil
* Lodenafil
* Mirodenafil
* MY-5445
* Nitrosoprodenafil
* Norcarbodenafil
* SCH-51866
* Sildenafil
* Sulfoaildenafil
* T-0156
* Tadalafil
* Udenafil
* Vardenafil

PDE7|

* BRL-50481

PDE9|

* BAY 73-6691
* PF-04447943
* Paraxanthine

PDE10|

* Balipodect
* Mardepodect
* MK-8189
* Papaverine
* TC-E 5005
* Tofisopam

PDE11|

BC11-38

Non-selective|

* Aminophylline
* Caffeine
* Choline theophyllinate
* CPX
* Dipyridamole
* Doxofylline
* Enprofylline
* Ibudilast
* IBMX
* Luteolin
* Pentoxifylline
* Propentofylline
* Theobromine
* Theophylline
* Zaprinast

Unsorted|

* Diazepam
* Diprophylline
* DPCPX
* Furafylline
* Lisofylline
* MDL-12330A
* Moxaverine
* Oxagrelate
* Pentifylline
* Proxyphylline
* Quercetin
* Satigrel
* Tolafentrine
* Trapidil

See also: Receptor/signaling modulators

This pharmacology-related article is a stub. You can help Wikipedia by expanding it.

|

* v
* t
* e

*[CID]: Compound ID
*[EPA]: U.S. Environmental Protection Agency
*[v]: View this template
*[t]: Discuss this template
*[e]: Edit this template